LifeStance Health Group, Inc. Common Stock (LFST) Stock
Key stats
- Market cap
- $4.92B
- Price / Earnings ratio
- 94.8x
- EPS (TTM)
- -$0.48
- Volume
- Loading
- 52-week high
- $13.56
- 52-week low
- $4.77
Source: third-party data provider, as of October 25, 2026
Compare with LFST
Recent news

Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
LFST

LifeStance Health CTO Sells 42,067 Shares for $541,402
LifeStance Health CTO Sells 42,067 Shares for $541,402
LFST

These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
LFST

Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
LFST
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 61.84
- MACD 12/26/9
- 0.06
- EMA 9 of MACD
- -0.00
- MACD histogram
- 0.06
- SMA 50
- $12.41
- Price above SMA 50
- EMA 50
- $12.06
- Price above EMA 50
- SMA 200
- $9.19
- Price above SMA 200
- EMA 200
- $9.54
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 23, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
LFST

LifeStance Health CTO Sells 42,067 Shares for $541,402
LifeStance Health CTO Sells 42,067 Shares for $541,402
LFST

These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
LFST

Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
LFST

5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
LFST

LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?
LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?
LFST

4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
LFST

Bet on These 5 Low-Leverage Stocks as Bond Yields Dip
Bet on These 5 Low-Leverage Stocks as Bond Yields Dip
LFST

LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know
LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know
LFST

5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence
5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence
LFST
News tone: automated (AI) classification of the article's content, not a price prediction.
About LifeStance Health Group, Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. David Patrick Bourdon | CEO & Director | 1969 |
| Mr. Kenneth Alan Burdick J.D. | Executive Chairman | 1959 |
| Mr. Ryan Bruce McGroarty | CFO & Treasurer | 1973 |
| Ms. Lisa Keise Miller | Chief Operating Officer & Principal Operating Officer | 1974 |
| Mr. Vukasin Paunovich | Chief Technology Officer | 1972 |
| Mr. Ryan Pardo J.D. | Chief Legal Officer & Secretary | 1977 |
| Ms. Ann Varanakis | Chief People Officer | 1978 |
| Ms. Monica Prokocki | Vice President of Investor Relations | — |
| Brooke Matthews | Director of Public Relations | — |
| Mr. Richard Hall | Chief Shared Services Officer | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of October 25, 2026
Technical indicators
- RSI 14
- 61.84
- MACD 12/26/9
- 0.06
- EMA 9 of MACD
- -0.00
- MACD histogram
- 0.06
- SMA 50
- $12.41
- Price above SMA 50
- EMA 50
- $12.06
- Price above EMA 50
- SMA 200
- $9.19
- Price above SMA 200
- EMA 200
- $9.54
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 23, 2026. Technical data, not a recommendation.
Analyst views
5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $13.00
- Average
- $15.20
- High
- $18.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +3.4 | -38.2 | +20.5 | |||||||||
| 2022 | -23.7 | +23.1 | +9.3 | -33.3 | +7.8 | -18.8 | +8.6 | +1.1 | +0.0 | +6.8 | -33.8 | -11.0 |
| 2023 | +13.5 | -5.0 | +55.1 | +8.8 | -0.1 | +9.7 | +5.0 | -12.4 | -13.0 | -11.3 | +20.5 | +19.5 |
| 2024 | -24.3 | +48.0 | -20.8 | -0.3 | -13.6 | -10.9 | +10.2 | +12.5 | +7.9 | -2.6 | +10.4 | -1.9 |
| 2025 | +5.6 | -3.1 | -15.8 | -0.9 | -8.9 | -12.1 | -20.2 | +44.6 | -2.3 | -10.1 | +32.1 | +9.8 |
| 2026 | +1.6 | +0.8 | -10.8 | +18.8 | +2.4 | +34.9 | -8.3 | +17.3 | -4.5 | +8.6 |



